Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl (5-bromo-3-(3-phenylisoxazol-5-yl)pyrazin-2-yl)-N-tert-butoxycarbonyl-carbamate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1232425-40-9

Post Buying Request

1232425-40-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1232425-40-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1232425-40-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,2,4,2 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1232425-40:
(9*1)+(8*2)+(7*3)+(6*2)+(5*4)+(4*2)+(3*5)+(2*4)+(1*0)=109
109 % 10 = 9
So 1232425-40-9 is a valid CAS Registry Number.

1232425-40-9Relevant academic research and scientific papers

Compounds Useful as Inhibitors of ATR Kinase

-

Paragraph 0202; 0203, (2013/05/21)

The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, a

AMINOPYRAZINE COMPOUNDS USEFUL AS INHIBITORS OF TRA KINASE

-

Page/Page column 60, (2012/10/18)

The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (I): wherein the variables are as defined herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1232425-40-9